Literature DB >> 10468703

Post-prandial ranitidine is superior to post-prandial omeprazole in control of gastric acidity in healthy volunteers.

R M Khoury1, P O Katz, D O Castell.   

Abstract

BACKGROUND: Episodic heartburn is a common problem, affecting over 40 million Americans. Although omeprazole provides excellent acid suppression when used daily, the use of omeprazole as on-demand therapy for episodic symptoms has not been extensively studied. AIM: To compare the onset and duration of post-prandial gastric acid suppression by omeprazole (10 and 20 mg) or ranitidine (75 and 150 mg) taken as single doses in healthy volunteers.
METHODS: Twenty-four healthy volunteers (14 male, 10 female, mean age 33.4 years, range 18-56 years) were given ranitidine (RAN) 75 mg or 150 mg vs. omeprazole (OME) 10 mg or 20 mg when pH returned to below 2 after breakfast, in a randomized open label crossover design, with a washout of at least 2 days between medications. Intragastric pH was monitored for 6 h. The time between drug ingestion and rise of gastric pH > 3 and 4, and total time pH remained > 3 and 4 during the 6 h post drug, was compared between groups using two way ANOVA and Wilcoxon matched pairs test.
RESULTS: The median time needed to pH > 4 was 204.5 min for RAN 75 mg, 186 min for RAN 150 mg and > 360 min for both OME 10 and 20 mg (P < 0.001 between the four groups). The median time that pH remained > 4 was 93 min for RAN 75 mg, 143.5 min for RAN 150 mg and 0 min for both OME 10 and 20 mg (P < 0.001 between the four groups). Both doses of RAN were significantly superior to both doses of OME, although no significant difference was found between the high and the low doses of either drugs. Similar results were found for pH > 3.
CONCLUSION: Ranitidine 75 or 150 mg provides more rapid increase in gastric pH to > 3 and > 4 compared to omeprazole 10 or 20 mg when taken at the end of the post-prandial period. These data suggest that ranitidine may be more effective for episodic post-prandial heartburn than omeprazole.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10468703     DOI: 10.1046/j.1365-2036.1999.00587.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  7 in total

1.  Early effects of oral administration of omeprazole and roxatidine on intragastric pH.

Authors:  Hiroshi Iida; Shingo Kato; Yusuke Sekino; Eiji Sakai; Takashi Uchiyama; Hiroki Endo; Kunihiro Hosono; Yasunari Sakamoto; Koji Fujita; Masato Yoneda; Tomoko Koide; Hirokazu Takahashi; Chikako Tokoro; Ayumu Goto; Yasunobu Abe; Noritoshi Kobayashi; Kensuke Kubota; Eiji Gotoh; Shin Maeda; Atsushi Nakajima; Masahiko Inamori
Journal:  J Zhejiang Univ Sci B       Date:  2012-01       Impact factor: 3.066

2.  Which has superior acid-suppressive effect, 10 mg omeprazole once daily or 20 mg famotidine twice daily? Effects of single or repeated administration in Japanese Helicobacter pylori-negative CYP2C19 extensive metabolizers.

Authors:  Tomohiko Shimatani; Masaki Inoue; Tomoko Kuroiwa; Mutsuko Moriwaki; Jing Xu; Kazuro Ikawa; Norifumi Morikawa; Susumu Tazuma
Journal:  Dig Dis Sci       Date:  2007-01-09       Impact factor: 3.199

Review 3.  On-demand and intermittent therapy for gastro-oesophageal reflux disease: economic considerations.

Authors:  John M Inadomi
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

4.  A glass of water immediately increases gastric pH in healthy subjects.

Authors:  George Karamanolis; Ioanna Theofanidou; Marina Yiasemidou; Evangelos Giannoulis; Konstantinos Triantafyllou; Spiros D Ladas
Journal:  Dig Dis Sci       Date:  2008-05-13       Impact factor: 3.199

5.  A randomized, double-blind, placebo-controlled clinical study of the histamine H2-receptor antagonist famotidine in Japanese patients with nonerosive reflux disease.

Authors:  Michio Hongo; Yoshikazu Kinoshita; Ken Haruma
Journal:  J Gastroenterol       Date:  2008-07-04       Impact factor: 7.527

6.  Intra-gastric pH following single oral administrations of rabeprazole and esomeprazole: double-blind cross-over comparison.

Authors:  Kenji Furuta; Yukie Kohata; Yasuhiro Fujiwara; Mitsushige Sugimoto; Takahiro Uotani; Mihoko Yamade; Shu Sahara; Hitomi Ichikawa; Takahisa Furuta; Kenta Nio; Ryuichi Iwakiri; Masahiko Inamori; Osamu Kawamura; Motoyasu Kusano; Mototsugu Kato; Noriyuki Kawami; Katsuhiko Iwakiri; Toshihisa Takeuchi; Kazuhide Higuchi; Masahito Aimi; Kohji Naora; Kazuma Fujimoto; Tetsuo Arakawa; Yoshikazu Kinoshita
Journal:  J Clin Biochem Nutr       Date:  2014-10-04       Impact factor: 3.114

7.  Proton Pump Inhibitor Therapy before and after Endoscopic Submucosal Dissection: A Review.

Authors:  Mitsushige Sugimoto; Jin Seok Jang; Yashiro Yoshizawa; Satoshi Osawa; Ken Sugimoto; Yoshihiko Sato; Takahisa Furuta
Journal:  Diagn Ther Endosc       Date:  2012-07-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.